Methamphetamine Use Disorder: Clinical Trials

1 completed. 1 Phase 3.

By phase and status

Phase	Trials	Status
Phase 3	1	Completed 1

Follow Methamphetamine Use Disorder: new trials by email Literature Review of Methamphetamine Use Disorder trials Research Report on Methamphetamine Use Disorder

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder Naltrexone: Vivitrol®, Placebo (PLB) Injectable, Bupropion: Wellbutrin XL® - Methamphetamine Use Disorder	Phase 3	Completed	University of Texas Southwestern Medical Center	403	2017-05-05	2026-10-27

Interventions

Injections (1)  ·  phospholamban (1)

Sponsors

University of Texas Southwestern Medical Center (1)

Countries

United States (1)

Top investigators

Madhukar Trivedi, MD (1)

Results publications

PMID 33497547, PMID 37245855, PMID 37377462, PMID 38665252, PMID 38856086, PMID 40623319, PMID 40767786, PMID 42180350, PMID 42504048

NIH funding

UG1DA020024 (1)